Recent clinical trials surrounding the medication Retatrutide , specifically the 120mg formulation ZPHC ZPHC, indicate a considerable impact on body mass reduction and associated health factors. Scientists posit that this dual acting , influencing both GLP-1 and GIP pathways , may offer a major i